The surgical sutures market size was estimated at USD 5.35 billion in 2025 and is projected to increase from USD 5.62 billion in 2026 to approximately USD 8.70 billion by 2035, growing at a CAGR of 4.98% from 2026 to 2035. The surgical sutures market is driven by the increasing in conditions, such as cardiovascular disorders, cancer, and diabetes requires frequent surgical interventions, boosting the need for wound closure solutions, innovations in the technology, and growing disposable income in the region.

Surgical sutures comprise the isolation of the sterile medical trends and devices essential for tissue approximation, wound closure, and hemostasis during surgical or trauma procedures. These materials provide significant benefits across various applications, including high tensile strength for surgical support, reduced risk of infection through antimicrobial coatings, and a faster recovery with less tissue trauma and scarring. Absorbable variants dissolve naturally to eliminate the need for removal, while non-absorbable options deliver permanent tissue support in high-tension environments, such as cardiovascular or orthopedic surgeries.
Surgical Sutures Market Trends
To combat post-operative complications, there is a strong shift toward using antibacterial and antimicrobial-coated sutures. These advanced threads actively inhibit bacterial colonization at the incision site, drastically reducing the risk of surgical site infections and improving healing times.
Synthetic suture materials, such as polypropylene and polyglactin, are rapidly replacing traditional natural sutures. Synthetic variants are preferred for their superior tensile strength, highly predictable absorption rates, and significantly lower risk of causing allergic or hypersensitizing tissue reactions.
Absorbable sutures are driving the market and taking the largest share due to trends that dissolve naturally into the body over time; they eliminate the need for patients to return to the clinic for suture removal, improving overall patient comfort and clinic workflow.
AI and ML are driving the surgical suture industry in particular through automated robotic assistance and computer vision. These technologies allow surgeons to analyze video footage from past surgeries to determine the most effective suturing and knot-tying techniques tailored to specific patient needs. AI-powered systems can provide real-time guidance and automatically stabilize robotic arms to ensure perfectly consistent stitch placement and reduce human error. ML algorithms enable healthcare providers to evaluate wound healing patterns, track hand movements, and anticipate postoperative complications.
| Report Coverage | Details |
| Market Size in 2026 | USD 5.62 Billion |
| Market Size by 2035 | USD 8.70 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 4.98% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Type, Filament, Application, Region |
| Market Analysis (Terms Used) | Value (USD Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Medtronic; Stryker; Smith+Nephew; Ethicon (Johnson & Johnson); B. Braun SE; Riverpoint Medical; Dynarex Corporation; Healthium Medtech Ltd; Lotus Surgicals Pvt Ltd (TI Medical, a Murugappa Group company); DemeTECH Corporation; Corza Medical; Advanced Medical Solutions Group plc; Meril |
Rising Surgical Volume and Minimally Invasive Surgeries
The scaling up of fundamental wound closure requirements across procedures, the shift towards minimally invasive surgeries, such as laparoscopic and robotic procedures, has driven the adoption of specialized suturing materials and automated devices. The MIS operations performed through smaller incisions in confined internal spaces, they require advanced, high-tensile sutures for precise tissue approximation. These evolving surgical techniques necessitate highly biocompatible and antimicrobial suture designs, ultimately expanding the market by demanding premium, value-added wound closure products.
Alternative Wound Closer Devices
The market growth is hindered by the offering of significantly faster application times and the reduction of overall procedural complexity. These nonfuture alternatives are increasingly preferred in various minimally invasive and emergency surgeries because they can minimize patient trauma and leave superior cosmetic results. Consequently, this shift in surgical preference directly decreases the demand for traditional suturing methods in specific clinical scenarios.
Smart and Personalized Sutures
The embedding of sensors and flexible electronics into the threads of these sutures enables real-time tracking of tissue conditions, inflammation, and temperature without disrupting the healing process. Additionally, custom-designed, bioactive threads are engineered to release localized drugs or growth factors, drastically reducing post-operative complications like infections. This technological shift expands market revenue by encouraging premium pricing and replacing traditional materials with high-value alternatives.
Why Did the Absorbable Segment Hold a 63% Share for the Surgical Sutures Market?
The absorbable segment held a dominant position in the market with a share of 63% in 2025. Owing to the rising preference for internal surgeries and faster patient recovery with reduced follow-up procedures. The availability of specialized absorbable materials maintains high tensile strength during the critical first few weeks of the wound healing process before safely dissolving.
The non-absorbable segment held a 37% share of the market in 2025, with the aging global population and the rising volume of complex, load-bearing surgeries ensuring a sustained, high-volume demand for these heavy-duty closure solutions across hospitals and surgical centers. While absorbable alternatives continue to advance, the absolute necessity for permanent, long-term tissue approximation secures non-absorbable sutures a vital and lucrative position in the medical device market.
Why Did the Monofilament Segment Lead the Surgical Sutures Market?
The monofilament segment registered its dominance over the market with a share of 56% in 2025, owing to the growing demand for minimally traumatic and infection-resistant suturing materials. The solid, uniform structure of monofilaments effectively eliminates these breeding grounds, making them highly desirable in infection-prone environments. It is exceptionally flexible with low suture memory, which improves handling for surgeons navigating tight, complex spaces during MIS procedures.
The multifilament segment held the 44% share of the market in 2025, with the braided surface providing friction, which gives the suture excellent knot retention. Surgeons prefer this to prevent the knot from untying or slipping in critical internal closures. These sutures are widely used in general surgery, orthopedics, and gynecology, which accounts for a massive volume of global surgical procedures.
Why Did the General Surgery Segment Lead the Surgical Sutures Market?
The general surgery segment registered its dominance over the market with a share of 34% in 2025, owing to the high global volume of routine and emergency surgical procedures. Expanding healthcare facilities in the developing regions allow for broader access to basic and advanced surgical treatments.
The ophthalmic surgery segment held the 9% share of the market in 2025, with the increasing cataract and vision correction surgeries worldwide. It is preferred in eye surgery because they offer superior tensile strength, minimizes tissue drag, reduces inflammation, and possesses excellent knot security.

The cardiovascular surgery segment held the 18% share of the market in 2025, due to the rising prevalence of cardiovascular diseases and cardiac interventions. Innovation in synthetic and braided materials has led to the creation of advanced sutures that improve tissue compliance and biocompatibility, making them highly sought after by cardiac surgeons.
The orthopedic surgery segment held the 16% share of the market in 2025, with the increasing sports injuries, aging populations, and joint replacement surgeries. An increase in active lifestyles and sports-related injuries has led to a surge in arthroscopic surgeries, which rely heavily on advanced sutures to anchor tissue to bone.
The neurological surgery segment held the 8% share of the market in 2025, due to the fact that neurological procedures are comparatively fewer and highly specialized. The high frequency of TBIs requiring emergency craniotomies or skull reconstructions significantly contributes to the demand for reliable wound closure devices.
The others segment held the 15% share of the market in 2025, with procedures fragmented across multiple niche medical specialties. Growing societal focus on physical appearance, coupled with less invasive anti-aging and cosmetic treatments, has heavily spiked the demand for specialized, fine-gauge sutures used in plastic surgery.
Why Did the North America Region Lead the Surgical Sutures Market?
The North America region registered its dominance over the market with a share of 38% in 2025, owing to the high healthcare expenditure, strong surgical volumes, and advanced hospital systems. The rapid adoption of robotic-assisted surgery and premium specialized antimicrobial-coated sutures leads to higher overall revenue.
U.S. Surgical Suture Market Trends
U.S’s dominance of absorbable variants and a strong shift toward antimicrobial-coated threats designed to lower surgical site infection rates. The rapid adoption of innovative knotless, branded sutures is enhancing procedural efficiency by reducing operating times and ensuring even tension distribution across wounds.

The Europe region held the 27% share of the market in 2025, due to the strong medical infrastructure, though growth is comparatively moderate due to market maturity. The region's strong preference for continuous surgical innovation benefits greatly from the integration.
U.K. Surgical Suture Market Trends
The U.K. significant shift toward absorbable variants that eliminate follow-up extraction procedures and streamline outpatient care workflows. The growing integration of clinically advanced antimicrobial coatings and barbed designs is engineered to mitigate surgical site infections while enhancing tensile strength.
The Asia Pacific segment held 24% share of the market in 2025, due to the rising healthcare investments and increasing surgical procedures. A rising preference for advanced, minimally invasive procedures has driven demand for specialized absorbable and knotless sutures. The presence of established and emerging regional manufacturers has made high-quality sutures more cost-effective and accessible.
China Surgical Suture Market Trends
China is rapidly pivoting toward high-performance absorbable synthetic polymers and premium antimicrobial coatings to displace traditional materials and mitigate infection rates. The accelerated adoption of knotless barbed sutures and high-precision threads is optimizing closure efficiency in complex, minimally invasive outpatient procedures.
The Latin America region held 6% share of the market in 2025, with the region increasingly prioritizing synthetic absorbable sutures over natural alternatives to lower hypersensitivity risks and better tissue healing. Expanding public health initiatives and the proliferation of private clinics are improving patient access to both emergency and elective surgical care.
The MEA region held 5% share of the market in 2025, due to the expanding aging demographic in the region, which is highly susceptible to age-related health conditions, which correspondingly increases the volume of surgeries performed. The availability of advanced surgical sutures improves patient outcomes and reduces infection risks.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has segmented the surgical sutures market.
By Type
By Filament
By Application
By Region